Showing results (401-410 of 3,788) with videos related to
Sort By:
Pageof 379
Oncoimmunology|August 2, 2014
Pancreatic cancer: Hurdles in the engineering of CAR-based immunotherapiesDaniel Abate-Daga, Steven A Rosenberg, Richard A MorganOncoimmunology|August 2, 2014
Hormesis in cancer immunology: Does the quantity of an immune reactant matter?Oliver Mt Pearce, Heinz Läubli, Jack Bui, et al.Oncoimmunology|August 8, 2014
Targeting the adenosine A2b receptor in the tumor microenvironment overcomes local immunosuppression by myeloid-derived suppressor cellsSilvana Morello, Lucio MieleOncoimmunology|August 13, 2014
Notch and TGFβ: Functional partners facilitating tumor progressionHidetaka Ohnuki, Giovanna TosatoOncoimmunology|May 21, 2013
Tumor-associated macrophages subvert T-cell function and correlate with reduced survival in clear cell renal cell carcinomaStefanie Regine Dannenmann, Julia Thielicke, Martina Stöckli, et al.Oncoimmunology|March 14, 2013
Intravaginal live attenuated Salmonella increase local antitumor vaccine-specific CD8+ T cellsLoane Decrausaz, Christelle Pythoud, Sonia Domingos-Pereira, et al.Oncoimmunology|March 14, 2013
T-cell suppression mediated by regulatory T cells infiltrating hepatic tumors can be overcome by GITRL treatmentAlexander Pedroza-Gonzalez, Jaap Kwekkeboom, Dave SprengersOncoimmunology|March 14, 2013
An independent endocytic pathway stimulates different monocyte subsets by the a2 N-terminus domain of vacuolar-ATPaseChristina Kwong, Alice Gilman-Sachs, Kenneth BeamanOncoimmunology|March 14, 2013
Signaling via MYD88 in the pancreatic tumor microenvironment: A double-edged swordConstantinos P Zambirinis, George MillerOncoimmunology|March 14, 2013
NKT cell adjuvants in therapeutic vaccines against hematological cancersStephen R Mattarollo, Mark J SmythPageof 379